Agilent Technologies Aktie

154,38USD -2,87USD -1,83%
Agilent Technologies für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 929138 / ISIN: US00846U1016

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 17 000 18 100 18 100 17 900 0
Umsatz pro Mitarbeiter in Mio. EUR 0,37 0,38 0,38 0,36 0,00

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 3 799 3 778 4 186 3 959 4 594
Summe Anlagevermögen 6 906 6 754 6 577 7 972 8 133
Summe Aktiva 10 705 10 532 10 763 11 931 12 727

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 5 316 5 227 4 918 6 033 5 986
Summe Eigenkapital 5 389 5 305 5 845 5 898 6 741
Summe Passiva 10 705 10 532 10 763 11 931 12 727

Adresse

5301 Stevens Creek Boulevard, 95051 Santa Clara
Telefon +1 (800) 227-9770
Internet http://www.agilent.com

Management

Adam S. Elinoff
Chief Financial Officer & Senior Vice President
Angelica Riemann
President-Agilent CrossLab Group
August Specht
Chief Technology Officer
Boon Hwee Koh
Non-Executive Chairman
Bret Morgan DiMarco
Secretary, Chief Legal Officer & Senior VP
Daniel K. Podolsky
Independent Director
Darlene J. S. Solomon
Chief Technology Officer & Senior Vice President
Dow R. Wilson
Independent Director
Fred Schwarz
Chief Strategy & Corporate Development Officer
George A. Scangos
Independent Director
Guillermo Gualino
Treasurer & Vice President
Jonah Kirkwood
Chief Commercial Officer & SVP-Agilent
Joydeep Ganguly
Chief Operations & Quality Officer
Judy Gawlik Brown
Director
Mala Anand
Independent Director
Meghan Henson
Chief Human Resource Officer & Senior VP
Mikael Dolsten
Independent Director
Otis W. Brawley
Independent Director
Padraig Mcdonnell
President, Chief Executive Officer & Director
Parmeet Ahuja
Investor Relations Contact
Pascal Soriot
Director
Rodney Gonsalves
Chief Accounting Officer, VP & Controller
Simon May
President-Diagnostics & Genomics Group
Sue H. Rataj
Independent Director
Tom Callihan
Chief Enterprise Transformation Officer